$664 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 55 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FLXN | FLEXION THERAPEUTICS INC | $20,367,000 | +51.0% | 983,924 | 0.0% | 3.07% | +92.6% | |
SLGL | SOL GEL TECHNOLOGIES | $9,799,000 | +90.8% | 571,382 | 0.0% | 1.48% | +143.2% | |
GEC | GREAT ELM CAP GROUP INC | $4,232,000 | -9.0% | 1,267,030 | 0.0% | 0.64% | +16.0% | |
ARQL | ARQULE INCcall | $1,996,000 | +178.4% | 100,000 | 0.0% | 0.30% | +254.1% | |
SONG | AKAZOO SA | $1,695,000 | -16.7% | 321,600 | 0.0% | 0.26% | +6.2% | |
KEMPHARM INCnote 5.500% 2/0 | $1,230,000 | -2.6% | 3,000,000 | 0.0% | 0.18% | +24.2% | ||
XLP | SELECT SECTOR SPDR TRsbi cons stpls | $617,000 | +2.5% | 9,800 | 0.0% | 0.09% | +31.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
ISHARES TR | 27 | Q3 2023 | 13.2% |
HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
AMAZON COM INC | 18 | Q3 2022 | 7.6% |
SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-15 |
13F-HR/A | 2024-03-18 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2024-02-06 |
SC 13G/A | 2023-11-29 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.